Radiopharm Theranostics (ASX:RAD) Dividends per Share : A$0.00 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Radiopharm Theranostics Dividends per Share?

Radiopharm Theranostics's dividends per share for the six months ended in Dec. 2023 was A$0.00. Its dividends per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$0.00. Its Dividend Payout Ratio for the six months ended in Dec. 2023 was 0.00. As of today, Radiopharm Theranostics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Radiopharm Theranostics Dividends per Share Historical Data

The historical data trend for Radiopharm Theranostics's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Radiopharm Theranostics Dividends per Share Chart

Radiopharm Theranostics Annual Data

Trend

Jun22

Jun23

Dividends per Share

Radiopharm Theranostics Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23
Dividends per Share	-	-	-	-	-

Competitive Comparison of Radiopharm Theranostics's Dividends per Share

For the Biotechnology subindustry, Radiopharm Theranostics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Radiopharm Theranostics's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Radiopharm Theranostics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Radiopharm Theranostics's Dividend Yield % falls into.

Radiopharm Theranostics Dividends per Share Calculation

Dividends paid to per common share.

Radiopharm Theranostics (ASX:RAD) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Radiopharm Theranostics's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	-0.072
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Radiopharm Theranostics Dividends per Share Related Terms

Thank you for viewing the detailed overview of Radiopharm Theranostics's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Radiopharm Theranostics (ASX:RAD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Radiopharm Theranostics Ltd (ASX:RAD) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

RDPTF:USA

Address

62 Lygon Street, Level 3, Carlton South, Melbourne, VIC, AUS, 3053

Website

https://www.radiopharmtheranostics.com

Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.

Radiopharm Theranostics (ASX:RAD) Headlines

No Headlines